RT Journal Article
T1 The lung ultrasound "Rule of 7" in the prognosis of COVID-19 patients: Results from a prospective multicentric study.
A1 Tung-Chen, Yale
A1 Gil-Rodrigo, Adriana
A1 Algora-Martín, Ana
A1 Llamas-Fuentes, Rafael
A1 Rodríguez-Fuertes, Pablo
A1 Marín-Baselga, Raquel
A1 Alonso-Martínez, Blanca
A1 Sanz Rodríguez, Elena
A1 Llorens Soriano, Pere
A1 Ramos-Rincón, José-Manuel
K1 C-reactive protein
K1 COVID-19
K1 Chest
K1 Emergency departments
K1 Logistic regression
K1 Medicina de urgencias
K1 Point-of-care
K1 Proteína C reactiva
K1 Regresión logística
K1 Tórax
AB There is growing evidence regarding the imaging findings of coronavirus disease 2019 (COVID-19) in lung ultrasound (LUS), however the use of a combined prognostic and triage tool has yet to be explored. To determine the impact of the LUS in the prediction of the mortality of patients with highly suspected or confirmed COVID-19.The secondary outcome was to calculate a score with LUS findings with other variables to predict hospital admission and emergency department (ED) discharge. Prospective study performed in the ED of three academic hospitals. Patients with highly suspected or confirmed COVID-19 underwent a LUS examination and laboratory tests. A total of 228 patients were enrolled between March and September 2020. The mean age was 61.9 years (Standard Deviation - SD 21.1). The most common findings in LUS was a right posteroinferior isolated irregular pleural line (53.9%, 123 patients). A logistic regression model was calculated, including age over 70 years, C-reactive protein (CRP) over 70mg/L and a lung score over 7 to predict mortality, hospital admission and discharge from the ED. We obtained a predictive model with a sensitivity of 56.8% and a specificity of 87.6%, with an AUC of 0.813 [p The combination of LUS, clinical and laboratory findings in this easy to apply "rule of 7" showed excellent performance to predict hospital admission and mortality.
YR 2021
FD 2021-09-04
LK http://hdl.handle.net/10668/22363
UL http://hdl.handle.net/10668/22363
LA en
LA es
DS RISalud
RD Apr 11, 2025